GSH/pH Dual Activatable Cross‐linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De‐Hijacking and in Situ ROS Amplification
Advanced Materials · 2024-01 · 36 (2)
DOI: 10.1002/adma.202304098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 23.11.2023. Verfasst von Suleixin Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, 999078, China. Hauptthemen laut MEDLINE: Iron, Neoplasms. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: University of Macau, Fundo para o Desenvolvimento das Ciências e da Tecnologia, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Ferroptosis‐related cancer therapy is limited by insufficient Fe 2+ /Fe 3+ redox pair and hydrogen peroxide (H 2 O 2 ) for producing lethal hydroxyl radicals (·OH). Although exogenous iron or ROS‐producing drugs can enhance ferroptosis, exploiting endogenous iron (labile iron pool, LIP) stored in ferritin and promoting ROS generation may be safer. Herein, a metal/drug‐free nanomedicine is developed for responsive LIP release and H 2 O 2 generation on the mitochondria membranes, amplifying hydroxyl radical production to enhance ferroptosis‐mediated antitumor effects. A glutathione(GSH)/pH dual activatable fluorinated and cross‐linked polyethyleneimine (PEI) with dialdehyde polyethylene glycol layer nanocomplex loaded with MTS‐KR‐SOD (Mitochondria‐targeting‐sequence‐KillerRed‐Superoxide Dismutase) and CRISPR/Cas9‐CA IX (Carbonic anhydrase IX (CA IX)) plasmids (FP@MC) are developed for enhanced ferroptosis through endogenous iron de‐hijacking and in situ ROS amplification. Two plasmids are constructed to knockdown CA IX and translate KillerRed‐SOD recombinant protein specifically on mitochondria membranes, respectively. The CA IX knockdown acidifies the intracellular environment, leading the release of LIP from ferritin as a “flare” to initiate endogenous chemodynamic therapy. Meanwhile, MTS‐KR‐SOD generates H 2 O 2 when irradiated by a 590 nm laser to assist chemodynamic therapy, leading to ROS amplification for mitochondria damage and lipid peroxide accumulation. The combined therapeutic effects aggravate cancer ferroptosis and suppress tumor growth, providing a new paradigm for amplifying ROS and iron ions to promote ferroptosis‐related cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, 999078, China.
- MoE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, 999078, China.
ORCID-Profile: Meiwan Chen
Förderung
- University of Macau
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
- the National Natural Science Foundation of China
- Universidade de Macau
Zitieren
APA
Yang, S., Wu, Y., Zhong, W., Chen, R., Wang, M., & Chen, M. (2024). GSH/pH Dual Activatable Cross‐linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De‐Hijacking and in Situ ROS Amplification. Advanced Materials, 36(2). https://doi.org/10.1002/adma.202304098
Vancouver
Yang S, Wu Y, Zhong W, Chen R, Wang M, Chen M. GSH/pH Dual Activatable Cross‐linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De‐Hijacking and in Situ ROS Amplification. Advanced Materials. 2024;36(2). doi:10.1002/adma.202304098
BibTeX
@article{Yang2024,
author = {Yang, Suleixin and Wu, Yi and Zhong, Wenzhao and Chen, Ruie and Wang, Meilin and Chen, Meiwan},
title = {GSH/pH Dual Activatable Cross‐linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De‐Hijacking and in Situ ROS Amplification},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {2},
doi = {10.1002/adma.202304098}
}
EUVIMED